vs
Side-by-side financial comparison of Dolphin Entertainment, Inc. (DLPN) and Immunovant, Inc. (IMVT). Click either name above to swap in a different company.
Dolphin Entertainment, Inc. is the larger business by last-quarter revenue ($15.6M vs $8.4M, roughly 1.9× Immunovant, Inc.). Dolphin Entertainment, Inc. runs the higher net margin — 6.5% vs -899.0%, a 905.5% gap on every dollar of revenue. On growth, Immunovant, Inc. posted the faster year-over-year revenue change (140.7% vs 27.0%).
Dolphin Entertainment, Inc. is an American entertainment marketing and production company based in Coral Gables, Florida. Founded in 1996 by Bill O'Dowd, the company produces television series and films aimed primarily at children and young adults, and owns public relations and marketing firms through acquisitions. Dolphin has also expanded into digital media, including non-fungible token (NFT) ventures and influencer marketing.
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative monoclonal antibody therapies for patients with serious, rare autoimmune and inflammatory diseases. Its lead product candidate covers multiple autoimmune indications, with core U.S. operations and a global market expansion strategy.
DLPN vs IMVT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2024
| Metric | | |
|---|---|---|
| Revenue | $15.6M | $8.4M |
| Net Profit | $1.0M | $-75.3M |
| Gross Margin | 96.6% | — |
| Operating Margin | 9.5% | -896.2% |
| Net Margin | 6.5% | -899.0% |
| Revenue YoY | 27.0% | 140.7% |
| Net Profit YoY | 152.0% | -26.7% |
| EPS (diluted) | $0.10 | $-0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $15.6M | — | ||
| Q3 25 | $14.8M | — | ||
| Q2 25 | $14.1M | — | ||
| Q1 25 | $12.2M | — | ||
| Q4 24 | $12.3M | — | ||
| Q3 24 | $12.7M | — | ||
| Q2 24 | $11.4M | — | ||
| Q1 24 | $15.2M | $8.4M |
| Q4 25 | $1.0M | — | ||
| Q3 25 | $-365.5K | — | ||
| Q2 25 | $-1.4M | — | ||
| Q1 25 | $-2.3M | — | ||
| Q4 24 | $-2.0M | — | ||
| Q3 24 | $-8.7M | — | ||
| Q2 24 | $-1.6M | — | ||
| Q1 24 | $-326.8K | $-75.3M |
| Q4 25 | 96.6% | — | ||
| Q3 25 | 95.6% | — | ||
| Q2 25 | 94.7% | — | ||
| Q1 25 | 97.2% | — | ||
| Q4 24 | 96.1% | — | ||
| Q3 24 | 98.0% | — | ||
| Q2 24 | 98.1% | — | ||
| Q1 24 | 84.8% | — |
| Q4 25 | 9.5% | — | ||
| Q3 25 | 2.1% | — | ||
| Q2 25 | -0.4% | — | ||
| Q1 25 | -14.6% | — | ||
| Q4 24 | -11.2% | — | ||
| Q3 24 | -64.3% | — | ||
| Q2 24 | -9.8% | — | ||
| Q1 24 | 1.1% | -896.2% |
| Q4 25 | 6.5% | — | ||
| Q3 25 | -2.5% | — | ||
| Q2 25 | -10.0% | — | ||
| Q1 25 | -19.1% | — | ||
| Q4 24 | -15.9% | — | ||
| Q3 24 | -68.5% | — | ||
| Q2 24 | -14.2% | — | ||
| Q1 24 | -2.1% | -899.0% |
| Q4 25 | $0.10 | — | ||
| Q3 25 | $-0.03 | — | ||
| Q2 25 | $-0.13 | — | ||
| Q1 25 | $-0.21 | — | ||
| Q4 24 | $-0.21 | — | ||
| Q3 24 | $-0.80 | — | ||
| Q2 24 | $-0.17 | — | ||
| Q1 24 | $-0.04 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.8M | $635.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $9.7M | $617.8M |
| Total Assets | $58.3M | $666.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.8M | — | ||
| Q3 25 | $7.8M | — | ||
| Q2 25 | $8.7M | — | ||
| Q1 25 | $7.1M | — | ||
| Q4 24 | $8.2M | — | ||
| Q3 24 | $5.7M | — | ||
| Q2 24 | $8.7M | — | ||
| Q1 24 | $6.4M | $635.4M |
| Q4 25 | $9.7M | — | ||
| Q3 25 | $8.4M | — | ||
| Q2 25 | $7.9M | — | ||
| Q1 25 | $9.3M | — | ||
| Q4 24 | $11.6M | — | ||
| Q3 24 | $13.6M | — | ||
| Q2 24 | $20.4M | — | ||
| Q1 24 | $20.3M | $617.8M |
| Q4 25 | $58.3M | — | ||
| Q3 25 | $60.0M | — | ||
| Q2 25 | $58.6M | — | ||
| Q1 25 | $58.6M | — | ||
| Q4 24 | $58.4M | — | ||
| Q3 24 | $57.3M | — | ||
| Q2 24 | $65.6M | — | ||
| Q1 24 | $65.1M | $666.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $576.6K | $-59.7M |
| Free Cash FlowOCF − Capex | — | $-59.8M |
| FCF MarginFCF / Revenue | — | -714.4% |
| Capex IntensityCapex / Revenue | 0.0% | 1.8% |
| Cash ConversionOCF / Net Profit | 0.57× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-214.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $576.6K | — | ||
| Q3 25 | $-2.4M | — | ||
| Q2 25 | $1.5M | — | ||
| Q1 25 | $-1.7M | — | ||
| Q4 24 | $850.2K | — | ||
| Q3 24 | $-1.7M | — | ||
| Q2 24 | $1.8M | — | ||
| Q1 24 | $-1.2M | $-59.7M |
| Q4 25 | — | — | ||
| Q3 25 | $-2.4M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-1.7M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-59.8M |
| Q4 25 | — | — | ||
| Q3 25 | -16.3% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -14.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -714.4% |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.8% |
| Q4 25 | 0.57× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
